Back to Journals » Cancer Management and Research » Volume 12

Clinical Investigation of the Efficacy and Safety of Anlotinib with Immunotherapy in Advanced Non-Small Cell Lung Cancer as Third-Line Therapy: A Retrospective Study

Total article views   HTML views PDF downloads Totals
4,785 Dovepress* 4,313+ 741 5,054
PubMed Central* 472 205 677
Totals 4,785 946 5,731
*Since 19 October 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar